Shawna May Kober, DPT | |
14 Elm St, Box 292, Argyle, NY 12809-7738 | |
(518) 744-2691 | |
Not Available |
Full Name | Shawna May Kober |
---|---|
Gender | Female |
Speciality | Physical Therapist |
Location | 14 Elm St, Argyle, New York |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1447687785 | NPI | - | NPPES |
Mailing Address | Practice Location Address |
---|---|
Shawna May Kober, DPT 14 Elm St, Box 292, Argyle, NY 12809-7738 Ph: () - | Shawna May Kober, DPT 14 Elm St, Box 292, Argyle, NY 12809-7738 Ph: (518) 744-2691 |
News Archive
This remarkable publication focuses on the importance of genetics in mental retardation, investigating the extent to which molecular diagnostic capability and the understanding of genetic causes have improved over recent years. As a result, clinical evaluation and diagnostic laboratory practice are now undergoing an unprecedented period of change.
The International Agency for Research on Cancer (IARC), the specialized cancer agency of the World Health Organization, today celebrates the 50th anniversary of its establishment with the launch of the book International Agency for Research on Cancer: The First 50 Years, 1965–2015.
AmerisourceBergen announced a unique offering designed to help hospitals and health systems achieve meaningful use readiness for electronic health records (EHR), regardless of the technology they are using.
XOMA Ltd., a leader in the discovery and development of therapeutic antibodies, announced that it has reached the enrollment goal of 325 patients for its Phase 2b dose-ranging clinical trial of XOMA 052, and that it expects patient enrollment to close in July 2010, with top-line results available in the first quarter of 2011. XOMA 052 is a therapeutic antibody candidate that inhibits the pro-inflammatory cytokine interleukin-1 beta (IL-1 beta) which drives the inflammatory cause of Type 2 diabetes.
A new study finds significant associations between antibodies for multiple oral bacteria and the risk of pancreatic cancer, adding support for the emerging idea that the ostensibly distant medical conditions are related.
› Verified 4 days ago